According to a recent study in PLoS Medicine, infants born to mothers who are overweight or obese may be at increased risk of experiencing birth asphyxia.
According to a recent study in PLoS Medicine, infants born to mothers who are overweight or obese may be at increased risk of experiencing birth asphyxia.
Researchers at the Karolinska Institutet performed a nationwide cohort study, using data taken from the Medical Birth Register for all live singleton term births in Sweden between 1992 and 2010. Odds ratios (ORs) for Apgar scores between 0 and 3 at 5 and 10 minutes, meconium aspiration syndrome, and neonatal seizures, which were adjusted for year of infant’s birth, maternal weight, maternal height, maternal age, parity, mother’s education, mother’s smoking habits, and country of birth, were obtained through logistic regression analyses.
Read: Obesity and weight gain in pregnancy
Of the 1,764,403 terms births that met specifications, 86% had data on early pregnancy body mass index (BMI) and Apgar scores. Infants with an Apgar score of 0 to 3 at 5 minutes (absolute risk = 0.8 per 1000) totaled 1380 and 894 had an Apgar score of 0 to 3 at 10 minutes (absolute risk = 0.5 per 1000). When compared with infants born to mothers with normal BMI (18.5 – 24.9), the adjusted ORs (95% confidence interval) for those with Apgar score 0 to 3 at 10 minutes were: BMI 25-29.9 (1.32, 1.10 – 1.58), BMI 30-34.9 (1.57, 1.20-2.07), BMI 35-39.9 (1.80, 1.15-2.82), and BMI ≥40 (3.41, 1.91 – 6.09). A similar increase with BMI was found for the ORs for meconium aspiration, Apgar scores of 0 to 3 at 5 minutes, and neonatal seizures. The researchers were quick to point out that the lack of data on neonatal resuscitation efforts and the effect of obstetric interventions were a limitation of the study.
Concluding that the risk of asphyxia in term infants does increase with maternal overweight and obesity, the investigators said the results should be confirmed in other populations. They also stressed that the prevention of obesity or overweight in women of reproductive age was highly important to improve perinatal health.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More